Actively Recruiting
Early Ageing During Therapy in AYA Cancer Patients
Led by University Medical Center Groningen · Updated on 2025-05-13
120
Participants Needed
1
Research Sites
176 weeks
Total Duration
On this page
Sponsors
U
University Medical Center Groningen
Lead Sponsor
U
UMCG Kanker Researchfonds
Collaborating Sponsor
AI-Summary
What this Trial Is About
Longitudinal cohort study; measurements before start of systemic therapy and one year later.
CONDITIONS
Official Title
Early Ageing During Therapy in AYA Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18-39 years at cancer diagnosis
- Have a confirmed cancer diagnosis by histology or cytology, including leukemia, (non-)Hodgkin lymphoma, testicular cancer, osteosarcoma, Ewing sarcoma, breast cancer, or cervical cancer
- Scheduled to start systemic therapy with curative intent
- Allowed treatments include surgery, radiotherapy, chemotherapy, and antibodies, given concurrently or sequentially
You will not qualify if you...
- Unable to understand the patient information letter and informed consent form
- Scheduled to be treated with immune checkpoint inhibitors or targeted therapy with angiogenesis inhibitors
- Previously treated with systemic therapy or radiotherapy for another malignancy, except for in situ carcinoma of the cervix or uterus and adequately treated basal or squamous cell skin carcinoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center Groningen
Groningen, Netherlands, 9713 GZ
Actively Recruiting
Research Team
J
J. Nuver, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here